NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Other financing activities (2017 - 2025)

Updated

NRX Pharmaceuticals' Other financing activities was $2.74 million in Q4 2025, up 43.5% from $1.91 million a year earlier.

Analysis

NRX Pharmaceuticals (NRXP) Other financing activities (2017 - 2025) Analysis & Trends

For FY2025, Other financing activities at NRX Pharmaceuticals came in at $3.09 million, down 22.2% from FY2024.

  • In earlier years, Other financing activities was $3.97 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 NRX Pharmaceuticals 103.58 Mn 55.17 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.09 Mn
Mar 31, 2025 -350,000.00
Dec 31, 2024 1.53 Mn
Sep 30, 2024 1.54 Mn
Mar 31, 2018 -7,500.00
Dec 31, 2017 -439,919.00
API Access

NRX Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NRXP&period=max&api_key=YOUR_API_KEY